Changing trends in type 2 diabetes mellitus treatment intensification, 2002-2010

The American journal of managed care

Volumn 21, Issue 5, 2015, Pages e288-e296

  McCoy, Rozalina G ^b   Zhang, Yuanhui ^b   Herrin, Jeph ^b   Denton, Brian T ^b   Mason, Jennifer E ^b   Montori, Victor M ^b   Smith, Steven A ^b   Shah, Nilay D ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; INCRETIN; METFORMIN; SULFONYLUREA DERIVATIVE;

ADOLESCENT; ADULT; AGE; AGED; COMBINATION DRUG THERAPY; COMORBIDITY; DEMOGRAPHY; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSURANCE; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RETROSPECTIVE STUDY; SEX DIFFERENCE; SOCIOECONOMICS; UNITED STATES; YOUNG ADULT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGE FACTORS; AGED; BLOOD GLUCOSE; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INCRETINS; INSURANCE CLAIM REVIEW; MALE; METFORMIN; MIDDLE AGED; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; SEX FACTORS; SOCIOECONOMIC FACTORS; SULFONYLUREA COMPOUNDS; UNITED STATES; YOUNG ADULT;

EID: 85016924979     PISSN: None     EISSN: 19362692     Source Type: Journal    
DOI: None     Document Type: Article

References (0)